Skip to content

Insulet PODD Current Debt

Current Debt at other companies

Eli Lilly logo
Eli LillyLLY
$4B-0.4%
Medtronic logo
MedtronicMDT
$1.79B-37.8%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$0
Abbott logo
AbbottABT
$4.41B+771%
Viatris logo
ViatrisVTRS
$1.93B+22,619%

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%
EPS (diluted)$1.30+160%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's current debt?
Insulet (PODD) reported current debt of $18.6M in Q1 2026.
How has Insulet's current debt changed year-over-year?
Insulet's current debt decreased by 77.6% year-over-year, from $83.1M to $18.6M.
What is the long-term trend for Insulet's current debt?
Over 5 years (2020 to 2025), Insulet's current debt has grown at a 3.4% compound annual growth rate (CAGR), from $15.6M to $18.4M.
What does current debt mean?
The amount of long-term debt that must be paid back within one year.
How do you interpret current debt?
An increase signals higher near-term cash outflow requirements, potentially impacting liquidity ratios.
How does current debt compare across companies?
Varies based on debt maturity profiles and refinancing strategies common among growth-stage medical technology firms.